The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart

Experimental Physiology

Volumn 98, Issue 5, 2013, Pages 1009-1027

  Brack, Kieran E ^a   Narang, Ravi ^a   Winter, James ^a   Ng, G André ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEBBISTATIN;

ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAM; HEART; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART VENTRICLE FIBRILLATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; QT INTERVAL; RABBIT;

ACTION POTENTIALS; ANIMALS; ELECTROPHYSIOLOGICAL PHENOMENA; HEART; HEART VENTRICLES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MALE; MYOCARDIAL CONTRACTION; PERFUSION; RABBITS; VENTRICULAR FIBRILLATION;

EID: 84876720688     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.069369     Document Type: Article

References (43)

1. Baker LC, Wolk R, Choi BR, Watkins S, Plan P, Shah A & Salama G (2004). Effects of mechanical uncouplers, diacetyl monoxime, and cytochalasin-D on the electrophysiology of perfused mouse hearts. Am J Physiol Heart Circ Physiol 287, H1771-H1779.
2. Biermann M, Rubart M, Moreno A, Wu J, Josiah-Durant A & Zipes DP (1998). Differential effects of cytochalasin D and 2, 3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J Cardiovasc Electrophysiol 9, 1348-1357.
3. Blanchard EM, Smith GL, Allen DG & Alpert NR (1990). The effects of 2, 3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles. Pflugers Arch 416, 219-221.
4. Brack KE, Coote JH & Ng GA (2010). Modulation of ventricular fibrillation initiation and action potential duration restitution by acetylcholine, effect of varying extracellular calcium concentration. Cardiovasc Res 87(Suppl 1), S106-S106.
5. Brack KE, Coote JH & Ng GA (2011). Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor blockade. Cardiovasc Res 91, 437-446.
6. Brack KE, Patel VH, Coote JH & Ng GA (2007). Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the isolated rabbit heart. J Physiol 583, 695-704.
7. Camici PG & Crea F (2007). Coronary microvascular dysfunction. N Engl J Med 356, 830-840.
8. Cao JM, Qu Z, Kim YH, Wu TJ, Garfinkel A, Weiss JN, Karagueuzian HS & Chen PS (1999). Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res 84, 1318-1331.
9. de Tombe PP, Burkhoff D & Hunter WC (1992). Comparison between the effects of 2-3 butanedione monoxime (BDM) and calcium chloride on myocardial oxygen consumption. J Mol Cell Cardiol 24, 783-797.
10. Dou Y, Arlock P & Arner A (2007). Blebbistatin specifically inhibits actin-myosin interaction in mouse cardiac muscle. Am J Physiol Cell Physiol 293, C1148-C1153.
11. Eddinger TJ, Meer DP, Miner AS, Meehl J, Rovner AS & Ratz PH (2007). Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin. J Pharmacol Exp Ther 320, 865-870.
12. Efimov IR, Ermentrout B, Huang DT & Salama G (1996). Activation and repolarization patterns are governed by different structural characteristics of ventricular myocardium: experimental study with voltage-sensitive dyes and numerical simulations. J Cardiovasc Electrophysiol 7, 512-530.
13. Farman GP, Tachampa K, Mateja R, Cazorla O, Lacampagne A & de Tombe PP (2008). Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch 455, 995-1005.
14. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW & Efimov IR (2007). Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4, 619-626.
15. Franz MR (1999). Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 41, 25-40.
16. Franz MR (2003). The electrical restitution curve revisited: steep or flat slope-which is better J Cardiovasc Electrophysiol 14, S140-S147.
17. Franz MR, Burkhoff D, Yue DT & Sagawa K (1989). Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res 23, 213-223.
18. Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, Karagueuzian HS, Weiss JN & Chen PS (2000). Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A 97, 6061-6066.
19. Jou CJ, Spitzer KW & Tristani-Firouzi M (2010). Blebbistatin effectively uncouples the excitation-contraction process in zebrafish embryonic heart. Cell Physiol Biochem 25, 419-424.
20. Kanlop N & Sakai T (2010). Optical mapping study of blebbistatin-induced chaotic electrical activities in isolated rat atrium preparations. J Physiol Sci 60, 109-117.
21. Karma A (1994). Electrical alternans and spiral wave breakup in cardiac tissue. Chaos 4, 461-472.
22. Kettlewell S, Walker NL, Cobbe SM, Burton FL & Smith GL (2004). The electrophysiological and mechanical effects of 2, 3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol 89, 163-172.
23. Kondo M, Nesterenko V & Antzelevitch C (2004). Cellular basis for the monophasic action potential. Which electrode is the recording electrode Cardiovasc Res 63, 635-644.
24. Limouze J, Straight AF, Mitchison T & Sellers JR (2004). Specificity of blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 54, 337-341.
25. Liu Y, Cabo C, Salomonsz R, Delmar M, Davidenko J & Jalife J (1993). Effects of diacetyl monoxime on the electrical properties of sheep and guinea pig ventricular muscle. Cardiovasc Res 27, 1991-1997.
26. Lou Q, Li W & Efimov IR (2012). The role of dynamic instability and wavelength in arrhythmia maintenance as revealed by panoramic imaging with blebbistatin vs. 2, 3-butanedione monoxime. Am J Physiol Heart Circ Physiol 302, H262-H269.
27. Maesako M, Araki J, Lee S, Doi Y, Imaoka T, Iribe G, Mohri S, Hirakawa M, Harada M & Suga H (2000). 2, 3-Butanedione monoxime suppresses primarily total calcium handling in canine heart. Jpn J Physiol 50, 543-551.
28. Mantravadi R, Gabris B, Liu T, Choi BR, de Groat WC, Ng GA & Salama G (2007). Autonomic nerve stimulation reverses ventricular repolarisation sequence in rabbit hearts. Circ Res 100, e72-e80.
29. Mustafa SJ, Morrison RR, Teng B & Pelleg A (2009). Adenosine receptors and the heart; role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 193, 161-188.
30. Ng GA, Brack KE, Patel VH & Coote JH (2007). Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. Cardiovasc Res 73, 750-760.
31. Nicolson WB, McCann GP, Brown PD, Sandilands AJ, Stafford PJ, Schlindwein FS, Samani NJ & Ng GA (2012). A novel surface electrocardiogram-based marker of ventricular arrhythmia risk in patients with ischemic cardiomyopathy. J Am Heart Assoc 1, e001552.
32. Ogura T, Shuba LM & McDonald TF (1995). Action potentials, ionic currents and cell water in guinea pig ventricular preparations exposed to dimethyl sulfoxide. J Pharmacol Exp Ther 273, 1273-1286.
33. Patel VH, Brack KE, Coote JH & Ng GA (2008). A novel method of measuring nitric-oxide-dependent fluorescence using 4, 5-diaminofluorescein (DAF-2) in the isolated Langendorff-perfused rabbit heart. Pflugers Arch 456, 635-645.
34. Ricco ML, Hua F, Lomonte DJ, Venator KR, Cerda-Gonzalez S & Gilmour RF Jr (2009). Effects of hypocalcemia on electrical restitution and ventricular fibrillation. Conf Proc IEEE Eng Med Biol Soc 2009, 4182-4185.
35. Sakai T (2006). Cytochalasin D as the depressant of contraction for the optical monitoring of action potentials in isolated rat atrium. J Physiol Sci 56, 385-388.
36. Salama G, Lombardi R & Elson J (1987). Maps of optical action potentials and NADH fluorescence in intact working hearts. Am J Physiol Heart Circ Physiol 252, H384-H394.
37. Stapleton MT, Fuchsbauer CM & Allshire AP (1998). BDM drives protein dephosphorylation and inhibits adenine nucleotide exchange in cardiomyocytes. Am J PhysiolHeart Circ Physiol 275, H1260-H1266.
38. Stowe DF, O'Brien WC, Chang D, Knop CS & Kampine JP (1997). Reversal of endothelin-induced vasoconstriction by endothelium-dependent and -independent vasodilators in isolated hearts and vascular rings. J Cardiovasc Pharmacol 29, 747-754.
39. Sutton PM, Taggart P, Opthof T, Coronel R, Trimlett R, Pugsley W & Kallis P (2000). Repolarisation and refractoriness during early ischaemia in humans. Heart 84, 365-369.
40. Swift LM, Asfour H, Posnack NG, Arutunyan A, Kay MW & Sarvazyan N (2012). Properties of blebbistatin for cardiac optical mapping and other imaging applications. Pflugers Arch 464, 503-512.
41. 2+ exchange current in guinea-pig cardiac ventricular myocytes. Br J Pharmacol 132, 1317-1325.
42. Weiss JN, Chen PS, Qu Z, Karagueuzian HS & Garfinkel A (2000). Ventricular fibrillation: how do we stop the waves from breaking Circ Res 87, 1103-1107.
43. Zabel M, Portnoy S & Franz MR (1995). Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 25, 746-752.